Abstract:Repair of bone defects presents a serious clinical challenge as it is difficult to restore bone function and regenerate bone loss. In the present study, the effects of lentivirus‑mediated transfection of bone marrow mesenchymal stem cells (BMSCs) with microRNA (miR)‑26a on bone regeneration were investigated in a mouse bone defect repair model. Marker of proliferation Ki67 (Ki67) staining was employed to detect the cell proliferation capacity and alkaline phosphatase (ALP) staining was used to investigate osteogenic differentiation. A mouse model of cranial bone defects was established. β‑tricalcium phosphate biomaterials co‑cultured with the transfected BMSCs were implanted into the defect areas of mouse models. Micro‑computed tomography, and hematoxylin and eosin and toluidine blue staining, were used to detect bone regeneration in the defect areas and the degradation of scaffolds. miR‑26a expression, and the mRNA and protein expression of osteogenesis‑associated cytokines, were detected using reverse transcription‑quantitative polymerase chain reaction and western blot analysis. Separated and cultured BMSCs highly expressed CD29 and CD105, but not CD34 and CD45, as determined by flow cytometry. miR‑26a expression and the positive cell rate of Ki67 and ALP staining in BMSCs transfected with pLVTHM‑miR‑26a were increased. The BMSC and negative control‑transfected BMSC groups exhibited increased bone regeneration in the defect areas, increased bone volume of newly formed bones, and elevated mRNA and protein expression of runt‑related transcription factor 2 (Runx2) and osteocalcin (OC), compared with the blank group. However, the miR‑26a‑transfected BMSC group exhibited further increases in bone regeneration and the volume of newly formed bones, and further elevations of the mRNA and protein expression levels of Runx2 and OC. The present findings demonstrated that lentivirus‑mediated modification of BMSCs enhanced bone regeneration during the repair of cranial bone defects in mice.

Lentiviral-Mediated Expression of Satb2 Promotes Osteogenic Differentiation of Bone Marrow Stromal Cells in Vitro and in Vivo

Roles of SATB2 in osteogenic differentiation and bone regeneration.

[Role of Transcription Factor Special AT-rich Binding Protein 2 in the Osteoblasts Differentiation of Bone Marrow Stromal Cells].

Transcription factor and bone marrow stromal cells in osseointegration of dental implants

Role of Special AT-Rich Sequence-Binding Protein 2 in the Osteogenesis of Human Dental Mesenchymal Stem Cells.

Enhanced osseointegration of titanium implant through the local delivery of transcription factor SATB2

SATB1 Promotes Osteogenic Differentiation of Diabetic Rat BMSCs Through MAPK Signalling Activation

Roles of SATB2 in site-specific stemness, autophagy and senescence of bone marrow mesenchymal stem cells

Critical-size Calvarial Bone Defects Healing in a Mouse Model with Silk Scaffolds and SATB2-modified Ipscs.

MicroRNA Expression Signature for Satb2-induced Osteogenic Differentiation in Bone Marrow Stromal Cells

Bone Morphogenetic Protein 2 Gene Transduction Enhances the Osteogenic Potential of Human Urine-Derived Stem Cells.

Construction of Satb2 Eukaryotic Expression Vector and Its Expression in Bone Marrow Mesenchyme Stem Cells

In vivo ectopic osteogenesis of mouse bone marrow stromal stem cells transfected with bone morphogenetic protein 2 and vascular endothelial growth factor 165 genes

Special AT-rich Sequence-Binding Protein 2 (satb2) Synergizes with Bmp9 and is Essential for Osteo/odontogenic Differentiation of Mouse Incisor Mesenchymal Stem Cells

Transplantation of osteoporotic bone marrow stromal cells rejuvenated by the overexpression of SATB2 prevents alveolar bone loss in ovariectomized rats

Role of Bone Morphogenetic Protein-2 in Osteogenic Differentiation of Mesenchymal Stem Cells

SATB2: A Versatile Transcriptional Regulator of Craniofacial and Skeleton Development, Neurogenesis and Tumorigenesis, and Its Applications in Regenerative Medicine

Expression of Sp7 in Satb2-induced osteogenic differentiation of mouse bone marrow stromal cells is regulated by microRNA-27a

Effects of BMP2 and VEGF165 on the Osteogenic Differentiation of Rat Bone Marrow-Derived Mesenchymal Stem Cells.

Study Of Bmp-2 Gene Modified Goat Bone Marrow Stromal Cells In Promoting New Bone Formation

Lentivirus‑mediated microRNA‑26a overexpression in bone mesenchymal stem cells facilitates bone regeneration in bone defects of calvaria in mice